Author:
Ding Chen,Huang Hua,Wu Di,Chen Chen,Hua Yu,Liu Jinghao,Li Yongwen,Liu Hongyu,Chen Jun
Abstract
FAT1, a substantial transmembrane protein, plays a pivotal role in cellular adhesion and cell signaling. Numerous studies have documented frequent alterations in FAT1 across various cancer types, with its aberrant expression being linked to unfavorable survival rates and tumor progression. In the present investigation, we employed bioinformatic analyses, as well as in vitro and in vivo experiments to elucidate the functional significance of FAT1 in pan-cancer, with a primary focus on lung cancer. Our findings unveiled FAT1 overexpression in diverse cancer types, including lung cancer, concomitant with its association with an unfavorable prognosis. Furthermore, FAT1 is intricately involved in immune-related pathways and demonstrates a strong correlation with the expression of immune checkpoint genes. The suppression of FAT1 in lung cancer cells results in reduced cell proliferation, migration, and invasion. These collective findings suggest that FAT1 has potential utility both as a biomarker and as a therapeutic target for lung cancer.
Reference38 articles.
1. Lung cancer 2020: epidemiology, etiology, and prevention;Bade;Clin Chest Med,2020
2. EGFR mutations and lung cancer;da Cunha Santos;Annu Rev Pathol,2011
3. Molecular cloning and tissue expression of FAT, the human homologue of the Drosophila fat gene that is located on chromosome 4q34-q35 and encodes a putative adhesion molecule;Dunne;Genomics,1995
4. Sleeping giants: emerging roles for the fat cadherins in health and disease;Sadeqzadeh;Med Res Rev,2014
5. Wnt/beta-catenin signaling, disease, and emerging therapeutic modalities;Nusse;Cell,2017